Covariation of amino acid positions in HIV-1 protease

被引:64
作者
Hoffman, NG
Schiffer, CA
Swanstrom, R
机构
[1] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27599 USA
[2] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA
关键词
protease; HIV-1; resistance; covariation; mutual information; protease inhibitor; variation;
D O I
10.1016/S0042-6822(03)00484-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have examined patterns of sequence variability for evidence of linked sequence changes in HIV-1 subtype B protease using translated sequences from protease inhibitor (PI) treated and untreated subjects downloaded from the Stanford HIV RT and Protease Sequence Database (http://hivdb.stanford.edu). The final data set size wits 648 sequences from untreated subjects (notx) and 531 for PI-treated subjects (tx). Each subject was uniquely represented by a single sequence. Mutual information was calculated for all pairwise comparisons of positions with nonconsensus amino acids in at least 5% of sequences; significance of pairwise association was assessed using permutation tests. In addition pairs of positions were assessed for linkage by comparing the observed occurrences of amino acid combinations to expected values. The mutual information statistic indicated linkage between nine pairs of sites in the untreated data set (10:93, 12:19, 35:38, 37:4 1, 62:71, 63:64, 71:77, 71:93, 77:93). Strong statistical support for linkage in the treated data set was seen for 32 pairs, eight involving position 10:7 involving position 71, with the rest being 12:19, 15:77, 20:36, 30:88, 35:36, 35:37, 36:62, 36:77, 46:82, 46:84, 48:54, 48:82, 54:82, 63:64, 63:90, 73:90, 77:93, and 84:90. Most associations were positive, although negative associations were seen for five pairs of interactions. Structural proximity suggests that numerous pairs may interact within a local environment. These interactions include two distinct clusters around 36/77 and 71/93. While some of these interactions may reflect fortuitous linkage in heavily treated subjects with many resistance mutations, others will likely represent important cooperative interactions that are amenable to experimental validation. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:536 / 548
页数:13
相关论文
共 40 条
[1]   Natural variation in HIV-1 protease, gag p7 and p6, and protease cleavage sites within Gag/Pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 [J].
Barrie, KA ;
Perez, E ;
Lamers, SL ;
Farmerie, WG ;
Dunn, BM ;
Sleasman, JW ;
Goodenow, MM .
VIROLOGY, 1996, 219 (02) :407-416
[2]   Covariability of V3 loop amino acids [J].
Bickel, PJ ;
Cosman, PC ;
Olshen, RA ;
Spector, PC ;
Rodrigo, AG ;
Mullins, JI .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (15) :1401-1411
[3]   Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients [J].
Birk, M ;
Sönnerborg, A .
AIDS, 1998, 12 (18) :2369-2375
[4]   Associations between amino acids in the evolution of HIV type 1 protease sequences under indinavir therapy [J].
Brown, AJL ;
Korber, BT ;
Condra, JH .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (03) :247-253
[5]   THE HUMAN LUMICAN GENE - ORGANIZATION, CHROMOSOMAL, LOCATION, AND EXPRESSION IN ARTICULAR-CARTILAGE [J].
GROVER, J ;
CHEN, XN ;
KORENBERG, JR ;
ROUGHLEY, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21942-21949
[6]   Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor [J].
Condra, JH ;
Holder, DJ ;
Schleif, WA ;
Blahy, OM ;
Danovich, RM ;
Gabryelski, LJ ;
Graham, DJ ;
Laird, D ;
Quintero, JC ;
Rhodes, A ;
Robbins, HL ;
Roth, E ;
Shivaprakash, M ;
Yang, T ;
Chodakewitz, JA ;
Deutsch, PJ ;
Leavitt, RY ;
Massari, FE ;
Mellors, JW ;
Squires, KE ;
Steigbigel, RT ;
Teppler, H ;
Emini, EA .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8270-8276
[7]   THE MIDAS DISPLAY SYSTEM [J].
FERRIN, TE ;
HUANG, CC ;
JARVIS, LE ;
LANGRIDGE, R .
JOURNAL OF MOLECULAR GRAPHICS, 1988, 6 (01) :13-&
[8]   In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632 [J].
Gong, YF ;
Robinson, BS ;
Rose, RE ;
Deminie, C ;
Spicer, TP ;
Stock, D ;
Colonno, RJ ;
Lin, PF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2319-2326
[9]   Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel [J].
Hirsch, MS ;
Brun-Vézinet, F ;
D'Aquila, RT ;
Hammer, SM ;
Johnson, VA ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Clotet, B ;
Conway, B ;
Demeter, LM ;
Vella, S ;
Jacobsen, DM ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2417-2426
[10]   In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: Mutations, kinetics, and frequencies [J].
Jacobsen, H ;
Hanggi, M ;
Ott, M ;
Duncan, IB ;
Owen, S ;
Andreoni, M ;
Vella, S ;
Mous, J .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) :1379-1387